Search Results 51-60 of 15061 for Tamoxifen
The study will determine breast density (MMG) and correlate with qLI. The study will also determine the influence of chemoprevention therapies such as tamoxifen ...
... tamoxifen; Developing a new drug to replace tamoxifen for people with low CYP2D6 enzyme activity; Developing a new drug for women with resistance to aromatase ...
... tamoxifen, for the treatment of estrogen receptor alpha-positive (ERα+) ... Using laboratory models, we demonstrated that endoxifen is primarily responsible for ...
... tamoxifen, for the treatment of estrogen receptor alpha positive (ERα+) ... Using lab models, we demonstrated that endoxifen is primarily responsible for the ...
Encorafenib is also used in combination with cetuximab to treat cancer of the colon and rectum that has spread and has the BRAF V600E mutations after previous ...
It is also used for women who have already had other cancer treatments (eg, tamoxifen). Female hormones that occur naturally in the body can increase the ...
... tamoxifen. Developing a new medicine to replace tamoxifen for people with low CYP2D6 enzyme activity. Developing a new medicine for breast cancer that is ...
Identifying genetic variations in the enzyme CYP2D6, which helps explain why some people with breast cancer don't respond to tamoxifen; Developing a new drug to ...
Lapatinib is also used together with letrozole to treat postmenopausal women with hormone-receptor positive and HER2-receptor positive metastatic breast cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.